CLPT
ClearPoint Neuro, Inc.
Price Chart
Latest Quote
$17.77
+0.96 (+5.71%)
Current Price
| Previous Close | $16.81 |
| Open | $17.59 |
| Day High | $18.85 |
| Day Low | $16.90 |
| Volume | 2,079,405 |
Stock Information
| Shares Outstanding | 29.99M |
| Total Debt | $63.59M |
| Cash Equivalents | $35.59M |
| Revenue | $40.61M |
| Net Income | $-29.07M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $532.91M |
| EPS (TTM) | $-1.00 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $428.06M |
| Sales | $40.61M |
| Income | $-29.07M |
| Book/sh | $0.63 |
| Cash/sh | $1.19 |
| Employees | 172 |
Financial Ratios
| Quick Ratio | 4.75 |
| Current Ratio | 5.79 |
| Debt/Eq | 337.50 |
Returns & Margins
| ROA | -24.98% |
| ROE | -149.72% |
| Gross Margin | 62.33% |
| Operating Margin | -69.90% |
| Profit Margin | -71.57% |
Ownership
| Insider Ownership | 8.45% |
| Institutional Ownership | 50.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -18.90 |
| PEG | 0.61 |
| P/S | 13.12 |
| P/B | 28.30 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $28.33 |
Technical Indicators
| SMA20 | $13.32 |
| SMA50 | $12.02 |
| SMA200 | $14.36 |
| RSI | 76.23 |
| ATR | 1.3986 |
| Shares Float | 26.25M |
| Short Float | 16.37% |
| Short Ratio | 7.83 |
| Volatility | 1.31 |
| Rel Volume | 2.21 |
Performance History
| Week | +28.40% |
| Month | +59.09% |
| Quarter | +93.57% |
| 6 Months | +28.58% |
| YTD | +26.66% |
| Year | +59.09% |
| 3 Years | +137.88% |
| 5 Years | -9.75% |
| 10 Years | +122.13% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $17.77 | 2,080,700 |
| 2026-06-17 | $16.81 | 6,884,400 |
| 2026-06-16 | $13.34 | 242,000 |
| 2026-06-15 | $13.52 | 324,800 |
| 2026-06-12 | $13.44 | 448,900 |
| 2026-06-11 | $13.84 | 359,400 |
| 2026-06-10 | $13.75 | 399,300 |
| 2026-06-09 | $13.59 | 338,900 |
| 2026-06-08 | $13.38 | 339,600 |
| 2026-06-05 | $12.89 | 625,900 |
| 2026-06-04 | $14.32 | 1,071,500 |
| 2026-06-03 | $13.30 | 742,700 |
| 2026-06-02 | $12.37 | 537,200 |
| 2026-06-01 | $12.64 | 517,100 |
| 2026-05-29 | $12.67 | 1,598,300 |
| 2026-05-28 | $12.24 | 472,000 |
| 2026-05-27 | $11.50 | 514,100 |
| 2026-05-26 | $11.82 | 507,600 |
| 2026-05-22 | $11.44 | 459,600 |
| 2026-05-21 | $11.70 | 404,700 |
| 2026-05-20 | $11.20 | 405,300 |
| 2026-05-19 | $11.17 | 368,600 |
About ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
đ° Latest News
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
Zacks âĸ 2026-06-18T10:36:00Z
ClearPoint Neuro Shares Jump as FDA Progress for UniQure Therapy Highlights Platform Value
InvestorsHub âĸ 2026-06-17T12:56:52Z
How The ClearPoint Neuro (CLPT) Narrative Is Shifting On Partnerships Valuation And FDA Risks
Simply Wall St. âĸ 2026-05-27T01:18:03Z
ClearPoint Neuro Inc (CLPT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth
GuruFocus.com âĸ 2026-05-19T01:01:43ZClearPoint Neuro Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T22:05:25Z
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
Zacks âĸ 2026-05-13T22:00:02Z
ClearPoint Neuro Q1 2026 Earnings Call Transcript
Benzinga âĸ 2026-05-13T21:38:59Z
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-13T21:35:02Z
HubSpot downgraded, Qualcomm upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-05-08T14:00:24Z
Here Are Fridayâs Top Wall Street Analyst Research Calls: Applied Materials, Devon Energy, Epam Systems, HubSpot, Nike, Shake Shack, Tapestry, Qualcomm, and More
24/7 Wall St. âĸ 2026-05-08T12:06:45Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $14,279,000 | $12,268,000 | $10,341,000 | $7,020,000 |
| Cost Of Revenue | $14,279,000 | $12,268,000 | $10,341,000 | $7,020,000 |
| Total Revenue | $36,971,000 | $31,390,000 | $23,955,000 | $20,551,000 |
| Operating Revenue | $36,971,000 | $31,390,000 | $23,955,000 | $20,551,000 |
| Expenses | ||||
| Interest Expense | $2,388,000 | $518,000 | - | $81,000 |
| Total Expenses | $61,135,000 | $51,124,000 | $46,401,000 | $36,883,000 |
| Other Income Expense | $-146,000 | $-40,000 | $-29,000 | $-22,000 |
| Other Non Operating Income Expenses | $-146,000 | $-40,000 | $-29,000 | $-22,000 |
| Net Non Operating Interest Income Expense | $-1,175,000 | $872,000 | $386,000 | $-81,000 |
| Interest Expense Non Operating | $2,388,000 | $518,000 | - | $81,000 |
| Operating Expense | $46,856,000 | $38,856,000 | $36,060,000 | $29,863,000 |
| Selling And Marketing Expense | $16,461,000 | $14,478,000 | $12,595,000 | $9,358,000 |
| General And Administrative Expense | $16,498,000 | $11,986,000 | $11,756,000 | $9,611,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Net Interest Income | $-1,175,000 | $872,000 | $386,000 | $-81,000 |
| Interest Income | $1,213,000 | $1,390,000 | $386,000 | - |
| Normalized Income | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Net Income From Continuing And Discontinued Operation | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Total Operating Income As Reported | $-24,164,000 | $-19,734,000 | $-22,446,000 | $-16,332,000 |
| Net Income Common Stockholders | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Net Income | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Net Income Including Noncontrolling Interests | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Net Income Continuous Operations | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Pretax Income | $-25,485,000 | $-18,902,000 | $-22,089,000 | $-16,435,000 |
| Interest Income Non Operating | $1,213,000 | $1,390,000 | $386,000 | - |
| Operating Income | $-24,164,000 | $-19,734,000 | $-22,446,000 | $-16,332,000 |
| Gross Profit | $22,692,000 | $19,122,000 | $13,614,000 | $13,531,000 |
| Per Share | ||||
| Diluted EPS | $-0.90 | $-0.70 | $-0.90 | $-0.68 |
| Basic EPS | $-0.90 | $-0.70 | $-0.90 | $-0.68 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-20,860,000 | $-16,481,000 | $-20,989,000 | $-15,577,000 |
| Reconciled Depreciation | $2,237,000 | $1,903,000 | $1,457,000 | $777,000 |
| EBITDA (Bullshit earnings) | $-20,860,000 | $-16,481,000 | $-20,989,000 | $-15,577,000 |
| EBIT | $-23,097,000 | $-18,384,000 | $-22,446,000 | $-16,354,000 |
| Diluted Average Shares | $28,315,254 | $27,027,692 | $24,605,212 | $24,181,854 |
| Basic Average Shares | $28,315,254 | $27,027,692 | $24,605,212 | $24,181,854 |
| Diluted NI Availto Com Stockholders | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Tax Provision | $55,000 | $12,000 | - | - |
| Research And Development | $13,897,000 | $12,392,000 | $11,709,000 | $10,894,000 |
| Selling General And Administration | $32,959,000 | $26,464,000 | $24,351,000 | $18,969,000 |
| Other Gand A | $16,498,000 | $11,986,000 | $11,756,000 | $9,611,000 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,626,000 | $25,389,000 | $20,132,000 | $35,859,000 |
| Total Assets | $97,747,000 | $39,189,000 | $42,661,000 | $55,490,000 |
| Total Non Current Assets | $34,147,000 | $5,826,000 | $6,489,000 | $4,310,000 |
| Other Non Current Assets | $1,702,000 | $735,000 | $495,000 | $581,000 |
| Goodwill And Other Intangible Assets | $21,394,000 | $0 | $1,041,000 | $1,028,000 |
| Other Intangible Assets | $13,922,000 | $484,000 | $1,041,000 | $1,028,000 |
| Current Assets | $63,600,000 | $33,363,000 | $36,172,000 | $51,180,000 |
| Other Current Assets | $2,769,000 | $1,683,000 | $1,910,000 | $1,723,000 |
| Inventory | $8,359,000 | $6,863,000 | $7,911,000 | $9,303,000 |
| Receivables | $6,549,000 | $4,713,000 | $3,211,000 | $2,665,000 |
| Accounts Receivable | $6,549,000 | $4,713,000 | $3,211,000 | $2,665,000 |
| Allowance For Doubtful Accounts Receivable | $-1,200,000 | $-1,100,000 | $-1,400,000 | $-100,000 |
| Gross Accounts Receivable | $7,749,000 | $5,813,000 | $4,611,000 | $2,765,000 |
| Cash Cash Equivalents And Short Term Investments | $45,923,000 | $20,104,000 | $23,140,000 | $37,489,000 |
| Cash And Cash Equivalents | $45,923,000 | $20,104,000 | $23,140,000 | $27,615,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $3,154,000 | - | - | - |
| Total Debt | $58,232,000 | $3,568,000 | $13,941,000 | $11,986,000 |
| Long Term Debt And Capital Lease Obligation | $57,538,000 | $3,011,000 | $13,517,000 | $11,425,000 |
| Long Term Debt | $49,077,000 | - | $9,949,000 | $9,893,000 |
| Current Debt And Capital Lease Obligation | $694,000 | $557,000 | $424,000 | $561,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $69,727,000 | $13,800,000 | $21,488,000 | $18,603,000 |
| Total Non Current Liabilities Net Minority Interest | $58,962,000 | $3,447,000 | $14,058,000 | $11,815,000 |
| Other Non Current Liabilities | $489,000 | - | - | - |
| Non Current Deferred Liabilities | $935,000 | $436,000 | $541,000 | $390,000 |
| Non Current Deferred Taxes Liabilities | $354,000 | $0 | - | - |
| Current Liabilities | $10,765,000 | $10,353,000 | $7,430,000 | $6,788,000 |
| Current Deferred Liabilities | $1,669,000 | $2,121,000 | $2,613,000 | $1,066,000 |
| Payables And Accrued Expenses | $4,042,000 | $2,790,000 | $1,446,000 | $2,337,000 |
| Payables | $1,256,000 | $1,340,000 | $393,000 | $272,000 |
| Accounts Payable | $1,256,000 | $1,340,000 | $393,000 | $272,000 |
| Equity | ||||
| Common Stock Equity | $28,020,000 | $25,389,000 | $21,173,000 | $36,887,000 |
| Total Equity Gross Minority Interest | $28,020,000 | $25,389,000 | $21,173,000 | $36,887,000 |
| Stockholders Equity | $28,020,000 | $25,389,000 | $21,173,000 | $36,887,000 |
| Other Equity Interest | $5,641,000 | - | - | - |
| Retained Earnings | $-216,910,000 | $-191,370,000 | $-172,456,000 | $-150,367,000 |
| Other | ||||
| Ordinary Shares Number | $29,368,760 | $27,617,415 | $24,652,729 | $24,578,983 |
| Share Issued | $29,368,760 | $27,617,415 | $24,652,729 | $24,578,983 |
| Tangible Book Value | $6,626,000 | $25,389,000 | $20,132,000 | $35,859,000 |
| Invested Capital | $77,097,000 | $25,389,000 | $31,122,000 | $46,780,000 |
| Working Capital | $52,835,000 | $23,010,000 | $28,742,000 | $44,392,000 |
| Capital Lease Obligations | $9,155,000 | $3,568,000 | $3,992,000 | $2,093,000 |
| Total Capitalization | $77,097,000 | $25,389,000 | $31,122,000 | $46,780,000 |
| Additional Paid In Capital | $238,995,000 | $216,483,000 | $193,382,000 | $187,008,000 |
| Capital Stock | $294,000 | $276,000 | $247,000 | $246,000 |
| Common Stock | $294,000 | $276,000 | $247,000 | $246,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $581,000 | $436,000 | $541,000 | $390,000 |
| Long Term Capital Lease Obligation | $8,461,000 | $3,011,000 | $3,568,000 | $1,532,000 |
| Current Deferred Revenue | $1,669,000 | $2,121,000 | $2,613,000 | $1,066,000 |
| Current Capital Lease Obligation | $694,000 | $557,000 | $424,000 | $561,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,360,000 | $4,885,000 | $2,947,000 | $2,824,000 |
| Current Accrued Expenses | $2,786,000 | $1,450,000 | $1,053,000 | $2,065,000 |
| Goodwill | $7,472,000 | $0 | - | - |
| Net PPE | $11,051,000 | $5,091,000 | $4,953,000 | $2,701,000 |
| Accumulated Depreciation | $-1,717,000 | $-1,343,000 | $-945,000 | $-1,769,000 |
| Gross PPE | $12,768,000 | $6,434,000 | $5,898,000 | $4,470,000 |
| Leases | $485,000 | $485,000 | $485,000 | $201,000 |
| Other Properties | $12,283,000 | $5,949,000 | $5,413,000 | $4,007,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-3,506,000 | $-2,259,000 | - | - |
| Finished Goods | $4,813,000 | $3,619,000 | $1,234,000 | $2,580,000 |
| Raw Materials | $7,052,000 | $5,503,000 | $6,466,000 | $6,513,000 |
| Other Inventories | - | $265,000 | $211,000 | $210,000 |
| Machinery Furniture Equipment | - | - | $0 | $262,000 |
| Other Short Term Investments | - | - | $0 | $9,874,000 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-24,447,000 | $-9,225,000 | $-14,771,000 | $-17,313,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-23,925,000 | $-8,950,000 | $-13,720,000 | $-16,167,000 |
| Cash Flow From Continuing Operating Activities | $-23,925,000 | $-8,950,000 | $-13,720,000 | $-16,167,000 |
| Investing Activities | ||||
| Capital Expenditure | $-522,000 | $-275,000 | $-1,051,000 | $-1,146,000 |
| Investing Cash Flow | $615,000 | $-275,000 | $8,949,000 | $-10,736,000 |
| Cash Flow From Continuing Investing Activities | $615,000 | $-275,000 | $8,949,000 | $-10,736,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $3,263,000 | $16,149,000 | $0 | $0 |
| Financing Cash Flow | $50,179,000 | $6,189,000 | $296,000 | $409,000 |
| Cash Flow From Continuing Financing Activities | $50,179,000 | $6,189,000 | $296,000 | $409,000 |
| Net Other Financing Charges | $-1,856,000 | $-424,000 | $-210,000 | $-336,000 |
| Net Common Stock Issuance | $3,263,000 | $16,149,000 | $0 | $0 |
| Common Stock Issuance | $3,263,000 | $16,149,000 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $0 | $-10,000,000 | $0 | - |
| Issuance Of Debt | $48,086,000 | $0 | - | - |
| Interest Paid Supplemental Data | $908,000 | $480,000 | $743,000 | $523,000 |
| Income Tax Paid Supplemental Data | $69,000 | $62,000 | $0 | $0 |
| End Cash Position | $46,973,000 | $20,104,000 | $23,140,000 | $27,615,000 |
| Beginning Cash Position | $20,104,000 | $23,140,000 | $27,615,000 | $54,109,000 |
| Changes In Cash | $26,869,000 | $-3,036,000 | $-4,475,000 | $-26,494,000 |
| Proceeds From Stock Option Exercised | $686,000 | $464,000 | $506,000 | $745,000 |
| Net Issuance Payments Of Debt | $48,086,000 | $-10,000,000 | $0 | - |
| Net Long Term Debt Issuance | $48,086,000 | $-10,000,000 | $0 | - |
| Long Term Debt Payments | $0 | $-10,000,000 | $0 | - |
| Long Term Debt Issuance | $48,086,000 | $0 | - | - |
| Net Business Purchase And Sale | $1,137,000 | $0 | - | - |
| Sale Of Business | $1,137,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-522,000 | $-275,000 | $-717,000 | $-253,000 |
| Purchase Of PPE | $-522,000 | $-275,000 | $-717,000 | $-253,000 |
| Change In Working Capital | $-9,814,000 | $1,399,000 | $-356,000 | $-4,289,000 |
| Change In Other Working Capital | $-319,000 | $-597,000 | $1,697,000 | $515,000 |
| Change In Other Current Liabilities | $-1,012,000 | $-869,000 | $-755,000 | $-541,000 |
| Change In Other Current Assets | $-195,000 | $-39,000 | $22,000 | $-6,000 |
| Change In Payables And Accrued Expense | $-7,520,000 | $3,105,000 | $-649,000 | $1,591,000 |
| Change In Prepaid Assets | $-397,000 | $262,000 | $-113,000 | $-1,216,000 |
| Change In Inventory | $-103,000 | $743,000 | $1,246,000 | $-4,421,000 |
| Change In Receivables | $-268,000 | $-1,206,000 | $-1,804,000 | $-211,000 |
| Changes In Account Receivables | $-268,000 | $-1,206,000 | $-1,804,000 | $-211,000 |
| Other Non Cash Items | $991,000 | $51,000 | $-69,000 | $-229,000 |
| Stock Based Compensation | $8,180,000 | $6,907,000 | $6,079,000 | $4,126,000 |
| Provisionand Write Offof Assets | $21,000 | $-296,000 | $1,258,000 | $-117,000 |
| Depreciation Amortization Depletion | $2,237,000 | $1,903,000 | $1,457,000 | $777,000 |
| Depreciation And Amortization | $2,237,000 | $1,903,000 | $1,457,000 | $777,000 |
| Amortization Cash Flow | $168,000 | $0 | - | - |
| Amortization Of Intangibles | $168,000 | $0 | - | - |
| Depreciation | $2,069,000 | $1,903,000 | $1,457,000 | $777,000 |
| Net Income From Continuing Operations | $-25,540,000 | $-18,914,000 | $-22,089,000 | $-16,435,000 |
| Net Investment Purchase And Sale | - | $0 | $10,000,000 | $-9,590,000 |
| Sale Of Investment | - | $0 | $10,000,000 | $12,000,000 |
| Net Intangibles Purchase And Sale | - | $0 | $-334,000 | $-893,000 |
| Purchase Of Intangibles | - | $0 | $-334,000 | $-893,000 |
| Purchase Of Investment | - | - | $0 | $-21,590,000 |
| Change In Accrued Expense | - | - | - | - |
| Change In Interest Payable | - | - | - | - |
Fetched: 2026-06-19